Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p

Aaron Reinke, Jenny C Y Chen, Sofia Aronova, Ted Powers

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

The target of rapamycin (TOR) kinase is an important regulator of growth in eukaryotic cells. In budding yeast, Tor1p and Tor2p function as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is specifically inhibited by the antibiotic rapamycin. Significant insight into TORC1 function has been obtained using rapamycin as a specific small molecule inhibitor of TOR activity. Here we show that caffeine acts as a distinct and novel small molecule inhibitor of TORC1: (i) deleting components specific to TORC1 but not TORC2 renders cells hypersensitive to caffeine; (ii) rapamycin and caffeine display remarkably similar effects on global gene expression; and (iii) mutations were isolated in Tor1p, a component specific to TORC1, that confers significant caffeine resistance both in vivo and in vitro. Strongest resistance requires two simultaneous mutations in TOR1, the first at either one of two highly conserved positions within the FRB (rapamycin binding) domain and a second at a highly conserved position within the ATP binding pocket of the kinase domain. Biochemical and genetic analyses of these mutant forms of Tor1p support a model wherein functional interactions between the FRB and kinase domains, as well as between the FRB domain and the TORC1 component Kog1p, regulate TOR activity as well as contribute to the mechanism of caffeine resistance.

Original languageEnglish (US)
Pages (from-to)31616-31626
Number of pages11
JournalJournal of Biological Chemistry
Volume281
Issue number42
DOIs
StatePublished - Oct 20 2006

Fingerprint

Sirolimus
Caffeine
Phosphotransferases
Mutation
Saccharomycetales
Molecules
Eukaryotic Cells
mechanistic target of rapamycin complex 1
Gene expression
Yeast
Molecular Biology
Adenosine Triphosphate
Anti-Bacterial Agents
Gene Expression
Growth
Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p. / Reinke, Aaron; Chen, Jenny C Y; Aronova, Sofia; Powers, Ted.

In: Journal of Biological Chemistry, Vol. 281, No. 42, 20.10.2006, p. 31616-31626.

Research output: Contribution to journalArticle

Reinke, Aaron ; Chen, Jenny C Y ; Aronova, Sofia ; Powers, Ted. / Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p. In: Journal of Biological Chemistry. 2006 ; Vol. 281, No. 42. pp. 31616-31626.
@article{7ea293bfb4104337909d8fa7c561776b,
title = "Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p",
abstract = "The target of rapamycin (TOR) kinase is an important regulator of growth in eukaryotic cells. In budding yeast, Tor1p and Tor2p function as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is specifically inhibited by the antibiotic rapamycin. Significant insight into TORC1 function has been obtained using rapamycin as a specific small molecule inhibitor of TOR activity. Here we show that caffeine acts as a distinct and novel small molecule inhibitor of TORC1: (i) deleting components specific to TORC1 but not TORC2 renders cells hypersensitive to caffeine; (ii) rapamycin and caffeine display remarkably similar effects on global gene expression; and (iii) mutations were isolated in Tor1p, a component specific to TORC1, that confers significant caffeine resistance both in vivo and in vitro. Strongest resistance requires two simultaneous mutations in TOR1, the first at either one of two highly conserved positions within the FRB (rapamycin binding) domain and a second at a highly conserved position within the ATP binding pocket of the kinase domain. Biochemical and genetic analyses of these mutant forms of Tor1p support a model wherein functional interactions between the FRB and kinase domains, as well as between the FRB domain and the TORC1 component Kog1p, regulate TOR activity as well as contribute to the mechanism of caffeine resistance.",
author = "Aaron Reinke and Chen, {Jenny C Y} and Sofia Aronova and Ted Powers",
year = "2006",
month = "10",
day = "20",
doi = "10.1074/jbc.M603107200",
language = "English (US)",
volume = "281",
pages = "31616--31626",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "42",

}

TY - JOUR

T1 - Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p

AU - Reinke, Aaron

AU - Chen, Jenny C Y

AU - Aronova, Sofia

AU - Powers, Ted

PY - 2006/10/20

Y1 - 2006/10/20

N2 - The target of rapamycin (TOR) kinase is an important regulator of growth in eukaryotic cells. In budding yeast, Tor1p and Tor2p function as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is specifically inhibited by the antibiotic rapamycin. Significant insight into TORC1 function has been obtained using rapamycin as a specific small molecule inhibitor of TOR activity. Here we show that caffeine acts as a distinct and novel small molecule inhibitor of TORC1: (i) deleting components specific to TORC1 but not TORC2 renders cells hypersensitive to caffeine; (ii) rapamycin and caffeine display remarkably similar effects on global gene expression; and (iii) mutations were isolated in Tor1p, a component specific to TORC1, that confers significant caffeine resistance both in vivo and in vitro. Strongest resistance requires two simultaneous mutations in TOR1, the first at either one of two highly conserved positions within the FRB (rapamycin binding) domain and a second at a highly conserved position within the ATP binding pocket of the kinase domain. Biochemical and genetic analyses of these mutant forms of Tor1p support a model wherein functional interactions between the FRB and kinase domains, as well as between the FRB domain and the TORC1 component Kog1p, regulate TOR activity as well as contribute to the mechanism of caffeine resistance.

AB - The target of rapamycin (TOR) kinase is an important regulator of growth in eukaryotic cells. In budding yeast, Tor1p and Tor2p function as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is specifically inhibited by the antibiotic rapamycin. Significant insight into TORC1 function has been obtained using rapamycin as a specific small molecule inhibitor of TOR activity. Here we show that caffeine acts as a distinct and novel small molecule inhibitor of TORC1: (i) deleting components specific to TORC1 but not TORC2 renders cells hypersensitive to caffeine; (ii) rapamycin and caffeine display remarkably similar effects on global gene expression; and (iii) mutations were isolated in Tor1p, a component specific to TORC1, that confers significant caffeine resistance both in vivo and in vitro. Strongest resistance requires two simultaneous mutations in TOR1, the first at either one of two highly conserved positions within the FRB (rapamycin binding) domain and a second at a highly conserved position within the ATP binding pocket of the kinase domain. Biochemical and genetic analyses of these mutant forms of Tor1p support a model wherein functional interactions between the FRB and kinase domains, as well as between the FRB domain and the TORC1 component Kog1p, regulate TOR activity as well as contribute to the mechanism of caffeine resistance.

UR - http://www.scopus.com/inward/record.url?scp=33846024055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846024055&partnerID=8YFLogxK

U2 - 10.1074/jbc.M603107200

DO - 10.1074/jbc.M603107200

M3 - Article

C2 - 16923813

AN - SCOPUS:33846024055

VL - 281

SP - 31616

EP - 31626

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 42

ER -